4//SEC Filing
Boyer David W. 4
Accession 0000914475-24-000201
CIK 0000914475other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 4:21 PM ET
Size
5.6 KB
Accession
0000914475-24-000201
Insider Transaction Report
Form 4
Boyer David W.
Chief Corp. Affairs Officer
Transactions
- Sale
Common Stock
2024-09-13$121.88/sh−3,461$421,828→ 1,672 total
Footnotes (3)
- [F1]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $120.31 to $122.48. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Includes an aggregate of 238 shares purchased on February 29, 2024 and August 30, 2024 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
Related Parties
1- filerCIK 0001909817
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 4:21 PM ET
- Size
- 5.6 KB